Phenotype–genotype analysis of 242 individuals with <scp>RASopathies</scp>: 18‐year experience of a tertiary center in Brazil
Débora Romeo Bertola, Matheus Augusto Araújo Castro, Guilherme Lopes Yamamoto, Rachel Sayuri Honjo, José Ricardo Magliocco Ceroni, Michele M. Buscarilli, Amanda Brasil de Freitas, Alexsandra C. Malaquias, Alexandre C. Pereira, Alexander A.L. Jorge, Maria Rita Passos‐Bueno, Chong Ae Kim
Abstract
We report the clinical and molecular data of a large cohort comprising 242 individuals with RASopathies, from a single Tertiary Center in Brazil, the largest study from Latin America. Noonan syndrome represented 76% of the subjects, with heterozygous variants in nine different genes, mainly PTPN11, SOS1, RAF1, LZTR1, and RIT1, detected by Sanger and next-generation sequencing. The latter was applied to 126 individuals, with a positive yield of 63% in genes of the RAS/MAPK cascade. We present evidence that there are some allelic differences in PTPN11 across distinct populations. We highlight the clinical aspects that pose more medical concerns, such as the cardiac anomalies, bleeding diathesis and proliferative lesions. The genotype-phenotype analysis between the RASopathies showed statistically significant differences in some cardinal features, such as craniofacial and cardiac anomalies, the latter also statistically significant for different genes in Noonan syndrome. We present two individuals with a Noonan syndrome phenotype, one with an atypical, structural cardiac defect, harboring variants in genes mainly associated with isolated hypertrophic cardiomyopathy and discuss the role of these variants in their phenotype.